Carregant...
A26 USE OF DRUG-TOLERANT ASSAYS IN INFLAMMATORY BOWEL DISEASE; WHAT DOES IT TELL US?
BACKGROUND: Therapeutic drug monitoring helps guide decision making in the treatment of IBD with anti-TNF therapies. Unlike older assays, newer drug-tolerant assays (such as the Prometheus assay) enable detection of drug antibodies in the presence of drug. The clinical relevance of drug antibodies d...
Guardat en:
| Publicat a: | J Can Assoc Gastroenterol |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Oxford University Press
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6512584/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jcag/gwz006.025 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|